LYCOS RETRIEVER 
Liver: Results
built 605 days ago
Animal livers are rich in iron and Vitamin A, and cod liver oil is commonly used as a dietary supplement. Very high doses of Vitamin A can be toxic; in 1913, Antarctic explorers Douglas Mawson and Xavier Mertz were both poisoned, the latter fatally, from eating husky liver. In the US, the USDA specifies 3000 μg per day as a tolerable upper limit, which amounts to about 50 g of raw pork liver or, as reported in a non scientific source, 3 g of polar-bear liver.[7] However, acute vitamin A poisoning is not likely to result from liver consumption, since it is present in a less toxic form than in many dietary supplements.[8]
Source:
HepatitisAn inflammation of the liver, with accompanying liver cell damage or cell death, caused most frequently by viral infection, but ... by certain drugs, chemicals, or poisons. May be either acute (of limited duration) or chronic (continuing). Symptoms include jaundice, nausea, vomiting, loss of appetite, tenderness in the right upper abdomen, aching muscles, and joint pain. In severe cases, liver failure may result.
Source:
Milk thistle extract is the most effective herbal preparation for enhanced liver health. And some practitioners have found that milk thistle seed extract can be very helpful in psoriasis cases. This herb is used extensively in Europe, and provides psoriasis help in about half the cases. When combined with the other therapies discussed, results are superior.
Source:
Based on promising results from ongoing preclinical studies of its RAP liver targeting program, Raptor has initiated a pre-IND program for HepTide(TM) (its liver targeting therapeutic conjugate using the RAP targeting platform). The Company's goal is to file an IND for this therapeutic conjugate with the Food and Drug Administration (the "FDA") by the end of the second calendar quarter of 2008. To help execute this plan the Company has retained Regulatory Professionals, Inc., a regulatory consulting firm experienced in working with the FDA in all aspects of regulatory affairs including preclinical and clinical support for pre- and post-approval products, and preparation and submission of regulatory filings for marketing approval.
Source:
An inflammation of the liver caused by the hepatitis C virus (HCV). HCV is transmitted primarily through direct exposure to infected blood through an opening in the skin or mucous membrane. The hepatitis C virus infects the liver, causing inflammation that results in damage to liver tissue.
Source:
[T]he results of this longitudinal study have shown progression of liver fibrosis in approximately one third of patients with NASH in a median follow-up of 4.3 years, the presence of obesity being the only factor associated with the progression. Patients with NASH who are obese should be included in controlled trials of experimental pharmacological therapy or should be treated promptly when some agreement exists regarding the efficacy of any drug in retarding the progression of fibrosis.
Source:
MORE ABOUT
Results